Thalys(SH:603716) Xin Lang Cai Jing·2025-12-19 02:15Core Viewpoint - The stock of Sely Medical has shown significant volatility, with a year-to-date increase of 209.42%, but a recent decline over the past 60 days of 27.63% [1][2]. Group 1: Stock Performance - As of December 19, Sely Medical's stock price was 22.34 yuan per share, with a trading volume of 3.55 billion yuan and a turnover rate of 7.71%, leading to a total market capitalization of 46.95 billion yuan [1]. - The stock has experienced a net outflow of 16.97 million yuan from major funds, with large orders buying 47.49 million yuan and selling 59.06 million yuan [1]. - The stock has appeared on the daily trading leaderboard 37 times this year, with the most recent appearance on August 26, where it recorded a net purchase of 146 million yuan [1]. Group 2: Company Overview - Sely Medical, established on February 23, 2004, and listed on October 31, 2016, is based in Wuhan, Hubei Province, and specializes in medical testing services and in vitro diagnostic products [2]. - The company's revenue composition includes 39.91% from IVD business, 38.01% from SPD business, and 22.08% from pure sales [2]. - The company operates within the pharmaceutical and biological industry, specifically in medical commerce and distribution, with concepts including antigen testing and smart healthcare [2]. Group 3: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million yuan, a year-on-year decrease of 39.64%, and a net profit attributable to shareholders of -87.24 million yuan, down 55.72% year-on-year [2]. - Since its A-share listing, Sely Medical has distributed a total of 27.07 million yuan in dividends, with no dividends paid in the last three years [3]. - As of September 30, 2025, the top ten circulating shareholders included several new institutional investors, indicating a shift in shareholder composition [3].